Supplier
Tufts Medical Center INC.
Tufts Medical Center INC. was paid $1.11M by Medicaid between Jan 2018 and Dec 2024, across 132 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 54% of everything it billed.
33Billing provider infoTUFTS MEDICAL CENTER INC.
BOSTON, MA 02111
BOSTON, MA 02111
33aNPI1326088006assigned 06/08/2006
33bProvider typePharmacy
28Total paid$1.11M
24GClaims119,442
24DCodes billed132
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pharmacy providers in Massachusetts
Rank by total paid#1 of 37
Median peer was paid$0.00
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,791 | $153K | |
| 2019 | 18,198 | $153K | |
| 2020 | 9,960 | $53K | |
| 2021 | 15,451 | $97K | |
| 2022 | 16,396 | $180K | |
| 2023 | 25,456 | $188K | |
| 2024incomplete | 17,190 | $291K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 54% | 41,092 | 31,130 | $602K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.8% | 1,112 | 1,072 | $109K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 4.9% | 3,274 | 3,235 | $55K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 4.4% | 190 | 190 | $49K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2.6% | 116 | 116 | $29K |
| 71046 | Radiologic examination, chest; 2 views | 2.5% | 2,080 | 2,028 | $27K |
| 77080 | 2.0% | 516 | 515 | $23K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 1.9% | 565 | 559 | $21K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.7% | 275 | 275 | $19K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.5% | 334 | 318 | $17K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1.5% | 118 | 117 | $16K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 1.2% | 256 | 239 | $13K |
120 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 2,866 | $13K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 540 | $11K |
| 71250 | <1% | 520 | $11K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 75 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 567 | $6K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 450 | $5K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 114 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 127 | $5K |
| 80061 | Lipid panel | <1% | 2,895 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 529 | $4K |
| J0178 | Injection, aflibercept, 1 mg | <1% | 14 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 120 | $3K |
| 20610 | <1% | 138 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 179 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,130 | $3K |
| Q3014 | Telehealth originating site facility fee | <1% | 1,088 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 134 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 3,073 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,909 | $2K |
| G0008 | Administration of influenza virus vaccine | <1% | 668 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,116 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 859 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,185 | $2K |
| 93017 | <1% | 121 | $1K | |
| 83735 | <1% | 2,676 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,716 | $1K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 264 | $1K |
| 92553 | <1% | 74 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,927 | $1K |
| 72100 | <1% | 66 | $1K | |
| 92083 | <1% | 959 | $955.65 | |
| 84100 | <1% | 1,747 | $824.76 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,836 | $801.13 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 251 | $800.00 |
| 90694 | <1% | 73 | $795.62 | |
| 90677 | <1% | 26 | $700.44 | |
| 0002A | <1% | 12 | $675.80 | |
| 90653 | <1% | 64 | $657.76 | |
| 97162 | <1% | 117 | $625.35 | |
| 82947 | <1% | 1,474 | $623.69 | |
| 0001A | <1% | 18 | $609.84 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 208 | $490.10 |
| 83970 | <1% | 343 | $417.38 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 57 | $410.48 |
| 82565 | <1% | 1,292 | $400.40 | |
| 90662 | <1% | 93 | $398.04 | |
| 85027 | <1% | 806 | $393.04 | |
| 83615 | <1% | 939 | $385.87 | |
| 84460 | <1% | 1,230 | $385.13 | |
| 84450 | <1% | 1,225 | $376.27 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 19 | $370.72 |
| 92557 | <1% | 147 | $370.56 | |
| 84550 | <1% | 1,022 | $360.26 | |
| 82570 | <1% | 1,635 | $340.26 | |
| 80051 | <1% | 699 | $318.20 | |
| 90686 | <1% | 201 | $317.79 | |
| 91322 | <1% | 41 | $298.34 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 38 | $294.61 |
| 82043 | <1% | 1,376 | $293.00 | |
| 0004A | <1% | 83 | $286.38 | |
| 92134 | <1% | 1,212 | $270.18 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 38 | $269.62 |
| 0064A | <1% | 35 | $236.79 | |
| 84520 | <1% | 973 | $232.89 | |
| 92133 | <1% | 1,088 | $215.96 | |
| 73030 | <1% | 27 | $204.76 | |
| 0134A | <1% | 29 | $190.92 | |
| 84075 | <1% | 662 | $185.50 | |
| 82607 | <1% | 152 | $180.96 | |
| 84466 | <1% | 273 | $180.06 | |
| 82247 | <1% | 629 | $174.72 | |
| 87517 | <1% | 36 | $171.36 | |
| 0124A | <1% | 91 | $143.19 | |
| 81002 | <1% | 1,399 | $142.68 | |
| 82728 | <1% | 262 | $136.30 | |
| 83880 | <1% | 25 | $117.78 | |
| 80069 | <1% | 516 | $115.85 | |
| 73562 | <1% | 29 | $99.18 | |
| 84153 | <1% | 78 | $98.32 | |
| 82248 | <1% | 174 | $91.65 | |
| 83540 | <1% | 272 | $91.30 | |
| 93296 | <1% | 13 | $82.32 | |
| 84156 | <1% | 658 | $80.74 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 33 | $50.70 |
| 82105 | <1% | 25 | $50.31 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 26 | $49.93 |
| 81001 | <1% | 248 | $41.56 | |
| 86140 | <1% | 174 | $31.08 | |
| 84439 | <1% | 69 | $27.06 | |
| 90480 | <1% | 39 | $19.02 | |
| 85652 | <1% | 172 | $13.50 | |
| 85610 | <1% | 234 | $13.11 | |
| 85007 | <1% | 19 | $11.40 | |
| 82948 | <1% | 397 | $10.08 | |
| 82040 | <1% | 28 | $9.90 | |
| 81003 | <1% | 559 | $9.76 | |
| 91300 | <1% | 80 | $0.03 | |
| J2704 | Injection, propofol, 10 mg | 0% | 653 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 111 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 559 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 377 | $0.00 |
| 92567 | 0% | 53 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 69 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 26 | $0.00 |
| 92136 | 0% | 50 | $0.00 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 26 | $0.00 |
| 73564 | 0% | 12 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 13 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 14 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 13 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 286 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 204 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 324 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 556 | $0.00 |
| 91312 | 0% | 55 | $0.00 | |
| 92015 | Determination of refractive state | 0% | 38 | $0.00 |
| 92555 | 0% | 42 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 39 | $0.00 |
| 0690T | 0% | 35 | $0.00 | |
| 91313 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMASSET, KEITH (SVP AND CPO)